Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05044403 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Phase 4 to Not applicablev2 Show 9 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date changed from estimate of Oct 31, 2022 to Mar 1, 2024
    • Start date changed from estimate of Oct 1, 2021 to Mar 1, 2023
    • Primary endpoints: 4 to 12
    • Enrollment target: 40 to 48
    • Study sites: 0 to 1
    • Study completion date: Dec 31, 2022 to Dec 20, 2025
    • Collaborators expanded, about 17 words
    • Study title shortened, about 12 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Low-level interventional clinical trial to evaluate the effectiveness and safety of extracorporeal support with hemoperfusion in critical patients with septic multiorgan dysfunction syndrome.
Trial Details
NCT Number NCT05044403
Lead Sponsor Hospital Clinic of Barcelona
Collaborators: Hospital General Universitario de Castellón, Hospital Universitario La Paz, Hospital de Granollers, Hospital General Universitario Santa Lucía
Conditions
(from sponsor)		 Hemoperfusion, Multiorgan Failure, Sepsis
Related terms Multiple Organ Failure, Sepsis
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov